Physician
Gindi, Edward
Gindi, Edward was paid $3.49M by Medicaid between Jan 2018 and Dec 2024, across 35 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 39% of everything it billed.
33Billing provider infoGINDI, EDWARD
BROOKLYN, NY 11229
BROOKLYN, NY 11229
33aNPI1013012772assigned 09/14/2006
33bProvider typeAllergy Physician
28Total paid$3.49M
24GClaims79,632
24DCodes billed35
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Allergy Physician providers in New York
Rank by total paid#4 of 54
Median peer was paid$33K
This provider vs. median106×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 6,847 | $251K | |
| 2019 | 11,093 | $394K | |
| 2020 | 13,622 | $527K | |
| 2021 | 12,569 | $604K | |
| 2022 | 11,495 | $558K | |
| 2023 | 12,755 | $606K | |
| 2024incomplete | 11,251 | $554K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 39% | 19,311 | 15,076 | $1.36M |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | 13% | 2,579 | 2,231 | $457K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 9.8% | 3,548 | 3,240 | $342K |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | 7.2% | 4,507 | 2,353 | $251K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 6.0% | 5,714 | 5,677 | $209K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 4.2% | 1,583 | 1,582 | $146K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 4.1% | 1,664 | 1,653 | $144K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 2.9% | 844 | 841 | $100K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 2.2% | 826 | 824 | $77K |
| 94010 | 1.5% | 1,992 | 1,839 | $52K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.3% | 7,293 | 6,410 | $46K |
| 92552 | 1.3% | 1,561 | 1,561 | $46K |
23 more codes
| 69210 | 1.1% | 825 | $37K | |
| 95117 | 1.1% | 4,144 | $37K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 321 | $32K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 3,239 | $31K |
| 87070 | <1% | 7,320 | $28K | |
| 92567 | <1% | 1,518 | $19K | |
| 90677 | <1% | 79 | $18K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,977 | $18K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 297 | $11K |
| 99441 | <1% | 235 | $10K | |
| 99442 | <1% | 161 | $8K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 64 | $6K |
| 86580 | <1% | 883 | $4K | |
| 81002 | <1% | 2,445 | $4K | |
| 95024 | <1% | 55 | $3K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,249 | $2K |
| 94060 | <1% | 12 | $479.19 | |
| 90686 | <1% | 12 | $173.15 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 13 | $172.40 |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 14 | $21.95 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 13 | $1.45 |
| 90688 | <1% | 36 | $0.34 | |
| 99000 | 0% | 2,298 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.